{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:44:38Z","timestamp":1771051478719,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.031","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T08:44:43Z","timestamp":1225529083000},"page":"88-92","source":"Crossref","is-referenced-by-count":17,"title":["Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro"],"prefix":"10.1016","volume":"27","author":[{"given":"Sudhanshu","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshu","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.10.031_bib1","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.10.031_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.aje.a121252","article-title":"Risks of smallpox vaccination complications in the United States","volume":"93","author":"Lane","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2008.10.031_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review. Part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.031_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.all.0000136758.66442.28","article-title":"Smallpox, vaccination and adverse reactions to smallpox vaccine","volume":"4","author":"Wollenberg","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2008.10.031_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0092-8674(92)90274-G","article-title":"A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection","volume":"71","author":"Alcami","year":"1992","journal-title":"Cell"},{"issue":"October","key":"10.1016\/j.vaccine.2008.10.031_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1997.tb01012.x","article-title":"Vaccinia virus immune evasion","volume":"159","author":"Smith","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2008.10.031_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion","volume":"21","author":"Seet","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2008.10.031_bib8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"issue":"May (Pt 2)","key":"10.1016\/j.vaccine.2008.10.031_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2008.10.031_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"January (6673)","key":"10.1016\/j.vaccine.2008.10.031_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2008.10.031_bib12","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.171.10.4984","article-title":"Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos","volume":"171","author":"Agrawal","year":"2003","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.10.031_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1189\/jlb.0706467","article-title":"Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells","volume":"81","author":"Agrawal","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2008.10.031_bib14","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.4049\/jimmunol.178.11.6912","article-title":"Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway","volume":"178","author":"Agrawal","year":"2007","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.10.031_bib15","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/eji.200324392","article-title":"Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro","volume":"33","author":"Jotwani","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.031_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-3-642-57276-0_21","article-title":"Functional subsets of memory T cells identified by CCR7 expression","volume":"251","author":"Sallusto","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.10.031_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.exger.2003.08.013","article-title":"Characterization of naive, memory and effector CD8+ T cells: effect of age","volume":"39","author":"Gupta","year":"2004","journal-title":"Exp Gerontol"},{"issue":"June","key":"10.1016\/j.vaccine.2008.10.031_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1196\/annals.1313.012","article-title":"Central memory and effector memory subsets of human CD4(+) and CD8(+) T cells display differential sensitivity to TNF-\u03b1-induced apoptosis","volume":"1050","author":"Gupta","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2008.10.031_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/375824","article-title":"Smallpox vaccination: a review. Part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2008.10.031_bib20","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.162.6.3256","article-title":"Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells","volume":"162","author":"Curtsinger","year":"1999","journal-title":"J Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.10.031_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"March (5102)","key":"10.1016\/j.vaccine.2008.10.031_bib22","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"issue":"September (4)","key":"10.1016\/j.vaccine.2008.10.031_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0147-9571(96)00013-6","article-title":"Soluble interferon-gamma receptors encoded by poxviruses","volume":"19","author":"Alcami","year":"1996","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.10.031_bib24","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/JVI.69.8.4633-4639.1995","article-title":"Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity","volume":"69","author":"Alcami","year":"1995","journal-title":"J Virol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2008.10.031_bib25","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1128\/JVI.74.16.7508-7517.2000","article-title":"Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail","volume":"74","author":"da Fonseca","year":"2000","journal-title":"J Virol"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2008.10.031_bib26","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:12Z","timestamp":1684617252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014023"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}